Home LiteratureArticle Details
PMID: 15249687 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.

Keckesova Z, Ylinen LM, Towers GJ

Abstract

The rhesus macaque tripartite motif containing protein TRIM5alpha specifically restricts HIV-1 infection at an early post-entry step before reverse transcription [Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P. & Sodroski, J. (2004) Nature 427, 848-853]. Here, we show that the human and African green monkey (AGM) TRIM5alpha genes encode Ref1 and Lv1 antiretroviral activities, respectively. Expression of TRIM5alpha in permissive cat cells renders them resistant to restriction-sensitive murine leukemia virus but not closely related insensitive virus. Disruption of TRIM5alpha expression in human and AGM cells with small interfering RNA rescues infectivity of restricted virus without affecting unrestricted virus. We also demonstrate that the activity of the murine restriction factor Fv1 depends on TRIM5alpha expression when Fv1 is expressed in human cells. Furthermore, a drug that modifies the behavior of the related promyelocytic leukemia protein PML specifically rescues infection by viruses restricted by human TRIM5alpha. Alignment of the TRIM5alpha proteins from rhesus macaque and AGM indicates an 18-aa insertion. We speculate that this insertion may contribute to the broader specificity of the AGM TRIM5alpha restriction as compared with the human and rhesus macaque proteins.

MeSH Terms
Amino Acid Sequence Animals Antiviral Agents/genetics,metabolism Antiviral Restriction Factors Arsenic Trioxide Arsenicals/metabolism Carrier Proteins/genetics,metabolism Cats Cell Line Chlorocebus aethiops/genetics Growth Inhibitors/metabolism Humans Leukemia Virus, Murine/genetics,metabolism Mice Molecular Sequence Data Oxides/metabolism R Factors/genetics,metabolism RNA, Small Interfering/genetics,metabolism Retroviridae/metabolism Retroviridae Infections/metabolism Sequence Alignment Sequence Homology, Amino Acid Tripartite Motif Proteins Ubiquitin-Protein Ligases
Chemicals
Antiviral Agents Antiviral Restriction Factors Arsenicals Carrier Proteins Growth Inhibitors Oxides RNA, Small Interfering Tripartite Motif Proteins TRIM5 protein, human Ubiquitin-Protein Ligases Arsenic Trioxide
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Keckesova Zuzana
Wohl Virion Center, Division of Infection and Immunity, University College London, London W1T 4JF, United Kingdom.
Ylinen Laura M J
Towers Greg J
References (43)
43 references, click to expand
  1. A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus.
    J Exp Med. 1971 Jun 1;133(6):1234-41 PMID: 4325133
  2. Clonal cells lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses.
    Virology. 1975 May;65(1):128-34 PMID: 167514
  3. Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus.
    J Virol. 1980 Jan;33(1):183-95 PMID: 6245227
  4. Synthesis and circularization of N- and B-tropic retroviral DNA Fv-1 permissive and restrictive mouse cells.
    Proc Natl Acad Sci U S A. 1980 May;77(5):2994-8 PMID: 6248878
  5. Positional cloning of the mouse retrovirus restriction gene Fv1.
    Nature. 1996 Aug 29;382(6594):826-9 PMID: 8752279
  6. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance.
    Virology. 1996 Nov 15;225(2):300-5 PMID: 8918916
  7. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia.
    Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3978-83 PMID: 9108090
  8. Protein fold analysis of the B30.2-like domain.
    Proteins. 1999 May 1;35(2):235-49 PMID: 10223295
  9. Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations.
    J Natl Cancer Inst. 1960 Apr;24:933-51 PMID: 14423465
  10. Species-specific, postentry barriers to primate immunodeficiency virus infection.
    J Virol. 1999 Dec;73(12):10020-8 PMID: 10559316
  11. A single amino acid change in the murine leukemia virus capsid gene responsible for the Fv1(nr) phenotype.
    J Virol. 2000 Jun;74(11):5385-7 PMID: 10799620
  12. Restriction of lentivirus in monkeys.
    Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11920-5 PMID: 12154231
  13. Use of a transient assay for studying the genetic determinants of Fv1 restriction.
    J Virol. 2000 Aug;74(16):7422-30 PMID: 10906195
  14. A conserved mechanism of retrovirus restriction in mammals.
    Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12295-9 PMID: 11027299
  15. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication.
    Mol Cell. 2001 Jun;7(6):1245-54 PMID: 11430827
  16. Abrogation of Ref1 retrovirus restriction in human cells.
    J Virol. 2002 Mar;76(5):2548-50 PMID: 11836433
  17. Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
    Gene Ther. 2002 Jul;9(14):932-8 PMID: 12085241
  18. Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains.
    J Virol. 2002 Aug;76(15):7705-12 PMID: 12097584
  19. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
    Nature. 2002 Aug 8;418(6898):646-50 PMID: 12167863
  20. Balanced polymorphism selected by genetic versus infectious human disease.
    Annu Rev Genomics Hum Genet. 2002;3:263-92 PMID: 12142357
  21. How acute promyelocytic leukaemia revived arsenic.
    Nat Rev Cancer. 2002 Sep;2(9):705-13 PMID: 12209159
  22. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism.
    Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11914-9 PMID: 12154227
  23. Death by deamination: a novel host restriction system for HIV-1.
    Cell. 2003 Aug 8;114(3):281-3 PMID: 12914693
  24. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors.
    Nat Med. 2003 Sep;9(9):1138-43 PMID: 12897779
  25. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
    Nat Med. 2003 Nov;9(11):1404-7 PMID: 14528300
  26. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.
    Nat Med. 2003 Nov;9(11):1398-403 PMID: 14528301
  27. Post-entry restriction of retroviral infections.
    AIDS Rev. 2003 Jul-Sep;5(3):156-64 PMID: 14598564
  28. Characterization of murine leukemia virus restriction in mammals.
    J Virol. 2003 Dec;77(24):13403-6 PMID: 14645596
  29. Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells.
    J Virol. 2004 Jan;78(2):1006-11 PMID: 14694132
  30. Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.
    J Virol. 2004 Mar;78(5):2169-78 PMID: 14963113
  31. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
    Nature. 2004 Feb 26;427(6977):848-53 PMID: 14985764
  32. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).
    Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3927-32 PMID: 14978281
  33. A dominant block to HIV-1 replication at reverse transcription in simian cells.
    Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13843-8 PMID: 12368468
  34. Immunologic profile of highly exposed yet HIV type 1-seronegative men.
    AIDS Res Hum Retroviruses. 2002 Sep 20;18(14):1051-65 PMID: 12396457
  35. Restriction of multiple divergent retroviruses by Lv1 and Ref1.
    EMBO J. 2003 Feb 3;22(3):385-94 PMID: 12554640
  36. As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity.
    J Virol. 2003 Mar;77(5):3167-80 PMID: 12584341
  37. Endocytosis of the viral chemokine receptor US28 does not require beta-arrestins but is dependent on the clathrin-mediated pathway.
    Traffic. 2003 Apr;4(4):243-53 PMID: 12694563
  38. Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience.
    Cancer. 2003 May 1;97(9):2218-24 PMID: 12712474
  39. Hypermutation of HIV-1 DNA in the absence of the Vif protein.
    Science. 2003 May 16;300(5622):1112 PMID: 12750511
  40. DNA deamination mediates innate immunity to retroviral infection.
    Cell. 2003 Jun 13;113(6):803-9 PMID: 12809610
  41. Restriction factors: a defense against retroviral infection.
    Trends Microbiol. 2003 Jun;11(6):286-91 PMID: 12823946
  42. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
    Nature. 2003 Jul 3;424(6944):99-103 PMID: 12808466
  43. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.
    Cell. 2003 Jul 11;114(1):21-31 PMID: 12859895
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2004-07-20
Epub
2004-00-12
Pages
10780-5
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC490011
Subset
IM
Databases
GENBANK
AY593973
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com